(Q43540466)

24 November 2017

title

Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease (English)

1 reference

24 November 2017

author name string

Maria-Christina Kyrtsonis

1

1 reference

24 November 2017

Theodoros P Vassilakopoulos

2

1 reference

24 November 2017

Marina P Siakantaris

3

1 reference

24 November 2017

Styliani I Kokoris

4

1 reference

24 November 2017

Despina A Gribabis

5

1 reference

24 November 2017

Maria N Dimopoulou

6

1 reference

24 November 2017

Maria K Angelopoulou

7

1 reference

24 November 2017

Gerassimos A Pangalis

8

1 reference

24 November 2017

publication date

1 April 2004

1 reference

European Journal of Haematology

24 November 2017

published in

1 reference

24 November 2017

volume

72

1 reference

24 November 2017

issue

4

1 reference

24 November 2017

page(s)

252-258

1 reference

Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.0902-4441.2003.00205.X

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0902-4441.2003.00205.X

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0902-4441.2003.00205.X

Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0902-4441.2003.00205.X

Cloning of a novel membrane-linked metalloproteinase from human myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0902-4441.2003.00205.X

Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0902-4441.2003.00205.X

Evidence of a role for a non-matrix-type metalloproteinase activity in the shedding of syndecan-1 from human myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0902-4441.2003.00205.X

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0902-4441.2003.00205.X

Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0902-4441.2003.00205.X

10.1046/J.0902-4441.2003.00205.X

21 January 2018

Identifiers

DOI

1 reference

24 November 2017

1 reference